EMA starts continual assessment of Sanofi's corona vaccine

The European Medicines Agency has now started to assess Sanofi's coronavirus vaccine frequently, to ensure faster authorization of the jab if it lives up to the authority's requirements.

Photo: Frank Hoermann/AP/Ritzau Scanpix

Another covid-19 vaccine has come a step closer to approval.

The European Medicines Agency (EMA) reported on Tuesday that it had started to continually assess Sanofi's covid-19 vaccine, Vidprevtyn.

Read the whole article

Get 14 days free access.
No credit card required.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Pfizer upgrades guidance for sales of covid-19 vaccine

The US pharmaceutical company Pfizer now predicts sales of its coronavirus vaccines will total USD 33.5bn this year. The previous estimate was UDS 26bn. Meanwhile, the company has revealed the guidance for its annual revenue.

Further reading

Related articles

Trial banner

Latest news

See all jobs